What longer-acting benzodiazepine can a patient be converted to, aside from Alprazolam (Xanax)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025 • View editorial policy

From the Guidelines

Estazolam is a suitable longer-acting benzodiazepine alternative to alprazolam, with a half-life that allows for less frequent dosing and reduced risk of interdose withdrawal symptoms. When considering a conversion from alprazolam, it's essential to choose a benzodiazepine with a longer half-life to minimize the risk of withdrawal symptoms and dependence. Estazolam, with its short- to intermediate-acting properties, is a viable option, as noted in the clinical guideline for the evaluation and management of chronic insomnia in adults 1. The recommended dosage for estazolam is 1-2 mg hs, with a starting dose of 0.5 mg hs in elderly or debilitated patients 2.

Some key points to consider when converting to estazolam or other longer-acting benzodiazepines include:

  • Starting with a conservative dose and adjusting based on response, as individual metabolism varies
  • Gradually reducing the alprazolam dose while introducing the longer-acting benzodiazepine over 1-2 weeks to prevent withdrawal symptoms
  • Monitoring for potential adverse effects, such as residual daytime drowsiness, and adjusting the dose accordingly
  • Counseling patients about the potential for disruptive sleep-related behaviors, such as sleepwalking or driving, and the importance of allowing appropriate sleep time and avoiding concomitant use of alcohol or other sedatives 2.

Other longer-acting benzodiazepine options, such as clonazepam or diazepam, may also be considered, but estazolam's pharmacokinetic profile and dosage flexibility make it a suitable choice for patients requiring a longer-acting alternative to alprazolam.

From the FDA Drug Label

OVERDOSAGE Overdosage of benzodiazepines is characterized by central nervous system depression ranging from drowsiness to coma. The FDA drug label does not answer the question.

From the Research

Longer-Acting Benzodiazepines

A patient can be converted to the following longer-acting benzodiazepines aside from Alprazolam (Xanax):

  • Clonazepam, which has a half-life of 20 to 80 hours 3
  • Diazepam, which can be used as a substitute in cases of benzodiazepine withdrawal 4, 5

Characteristics of Longer-Acting Benzodiazepines

The longer-acting benzodiazepines have several characteristics that make them useful for certain patients:

  • Clonazepam has a relatively long half-life, which permits less frequent dosing and more continuous control of anxiety 6
  • Diazepam has a longer half-life compared to some other benzodiazepines, making it suitable for substitution in cases of withdrawal 5

Medical Management of Benzodiazepine Dependence

The medical management of benzodiazepine dependence includes:

  • Graded reduction of the current benzodiazepine dosage
  • Substitution of a long-acting benzodiazepine
  • Phenobarbital substitution 5

References

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Benzodiazepine dependence and withdrawal: identification and medical management.

The Journal of the American Board of Family Practice, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.